ABCA4 and retinitis pigmentosa 1: Functional efficacy is validated using preclinical models such as rd10 mice (a model of RP) and ABCA4-deficient mice (Stargardt disease), where optokinetic response testing assesses visual acuity and ERG measures photoreceptor function [176,186].